Chemopreventive effect of squalene on colon cancer.

Epidemiologic and laboratory studies suggest a cancer protective effect and/or lack of a tumor promoting effect by dietary olive oil as compared with other types of non-marine oils. Squalene, a constituent of olive oil, and a key intermediate in cholesterol synthesis may be regarded as partially responsible for the beneficial effects of olive oil, which include decreased mortality rates among populations with high olive oil consumption. Thus, in this study we have assessed the chemopreventive efficacy of squalene on azoxymethane (AOM)-induced colonic aberrant crypt foci (ACF). In addition, we measured the effect of squalene on serum cholesterol levels in the rats. Male F34 rats (5 weeks old) were fed the control diet (modified AIN-76A) or experimental diets containing 1% squalene or 320 p.p.m. sulindac. Two weeks later, all animals except those in vehicle (normal saline)-treated groups were s.c. injected with AOM (15 mg/kg body wt, once weekly for 2 weeks). At 16 weeks of age, all rats were killed, colons were evaluated for ACF and serum was assayed for the cholesterol levels. As expected, dietary administration of sulindac suppressed ACF development and reduced crypt multiplicity, i.e. number of aberrant crypts/focus. Administration of dietary squalene inhibited total ACF induction and crypt multiplicity by approximately >46% (P < 0.001). Further, squalene at a level of 1% did not show any significant effect on serum cholesterol levels. Our finding that squalene significantly suppresses colonic ACF formation and crypt multiplicity strengthens the hypothesis that squalene possesses chemopreventive activity against colon carcinogenesis.

[1]  K. Katsouyanni,et al.  The macronutrient composition of the Greek diet: estimates derived from six case-control studies. , 1993, European journal of clinical nutrition.

[2]  V. Steele,et al.  Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[3]  B. Trock,et al.  Dietary fiber, vegetables, and colon cancer: critical review and meta-analyses of the epidemiologic evidence. , 1990, Journal of the National Cancer Institute.

[4]  K. Kinzler,et al.  Molecular determinants of dysplasia in colorectal lesions. , 1994, Cancer research.

[5]  S. Tanaka,et al.  Intensification of host's immunity by squalene in sarcoma 180 bearing ICR mice. , 1983, Journal of pharmacobio-dynamics.

[6]  E. Rimm,et al.  Consumption of olive oil and specific food groups in relation to breast cancer risk in Greece. , 1995, Journal of the National Cancer Institute.

[7]  J. Goldstein,et al.  Regulation of the mevalonate pathway , 1990, Nature.

[8]  B. L. Van Duuren,et al.  Cocarcinogenic and tumor-promoting agents in tobacco carcinogenesis. , 1976, Journal of the National Cancer Institute.

[9]  P. Fu,et al.  Enzymatic determination of total serum cholesterol. , 1974, Clinical chemistry.

[10]  S. Piantadosi,et al.  Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. , 1993, The New England journal of medicine.

[11]  D. Kritchevsky,et al.  Squalene Feeding in Experimental Atherosclerosis , 1953, Circulation research.

[12]  L. Cohen,et al.  Diet, Nutrition, and Cancer A Critical Evaluation , 1985 .

[13]  G A Colditz,et al.  Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. , 1990, The New England journal of medicine.

[14]  S. Akiyama,et al.  Potentiation by squalene of antitumor effect of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-nitros ourea in a murine tumor system. , 1985, Japanese journal of cancer research : Gann.

[15]  J. Mathews Sharks still intrigue cancer researchers. , 1992, Journal of the National Cancer Institute.

[16]  W. Willett,et al.  Diet and health: what should we eat? , 1994, Science.

[17]  C. Der,et al.  Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  T. P. Pretlow,et al.  Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. , 1992, Carcinogenesis.

[19]  S. Amin,et al.  Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon. , 1993, Cancer research.

[20]  S. Ishikawa,et al.  Environmental factors of cancer of the colon and rectum II. Japanese epidemiological data , 1969, Cancer.

[21]  E. Wynder,et al.  Environmental factors of cancer of the colon and rectum , 1967, Cancer.

[22]  T. Strandberg,et al.  Metabolic variables of cholesterol during squalene feeding in humans: comparison with cholestyramine treatment. , 1990, Journal of lipid research.

[23]  T. Strandberg,et al.  Variations of hepatic cholesterol precursors during altered flows of endogenous and exogenous squalene in the rat. , 1989, Biochimica et biophysica acta.

[24]  D. Ney,et al.  Dietary olive and safflower oils in promotion of DMBA-induced mammary tumorigenesis in rats. , 1990, Nutrition and cancer.

[25]  C. Rao,et al.  Modulating effect of amount and types of dietary fat on ornithine decarboxylase, tyrosine protein kinase and prostaglandins production during colon carcinogenesis in male F344 rats. , 1993, Carcinogenesis.

[26]  E. Kaplan,et al.  K-ras mutations in putative preneoplastic lesions in human colon. , 1993, Journal of the National Cancer Institute.

[27]  T. P. Pretlow,et al.  Aberrant crypts in human colonic mucosa: Putative preneoplastic lesions , 1992, Journal of cellular biochemistry. Supplement.

[28]  V. Steele,et al.  Chemoprevention of Colon Carcinogenesis by Sulindac , a Nonsteroidal Anti-inflammatory Agent 1 , 2022 .

[29]  R. Bird,et al.  Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: earliest recognizable precursor lesions of experimental colon cancer. , 1992, Carcinogenesis.

[30]  M. Murakoshi,et al.  Inhibition by squalene of the tumor‐promoting activity of 12‐O‐Tetradecanoylphorbol‐13‐acetate in mouse‐skin carcinogenesis , 1992, International journal of cancer.

[31]  E. R. Plunkett,et al.  Dietary fat and mammary cancer. , 1968, Canadian Medical Association journal.

[32]  H. Mizunuma,et al.  [Studies on antitumor activity of squalene and its related compounds]. , 1986, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[33]  W. Willett,et al.  Dietary fat, olive oil intake and breast cancer risk , 1994, International journal of cancer.

[34]  A. Medline,et al.  Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions. , 1991, Cancer research.

[35]  N. Kohl,et al.  Development of inhibitors of protein farnesylation as potential chemotherapeutic agents , 1995, Journal of cellular biochemistry. Supplement.